Harrison's advances in cardiology /

Harrison's advances in cardiology /

Saved in:
Bibliographic Details
Imprint:New York : McGraw-Hill, c2003.
Description:xxvii, 645 p. : ill. (some col.) ; 24 cm.
Language:English
Subject:
Cardiology.
Cardiovascular system -- Diseases -- Treatment.
Cardiology.
Cardiovascular system -- Diseases -- Treatment.
Format: Print Book
URL for this record:http://pi.lib.uchicago.edu/1001/cat/bib/4754043
Hidden Bibliographic Details
Varying Form of Title:Advances in cardiology
Other authors / contributors:Braunwald, Eugene, 1929-
ISBN:0071370889
Notes:Includes bibliographical references and index.
committed to retain 20170930 20421213 HathiTrust

MARC

LEADER 00000cam a22000004a 4500
001 4754043
003 ICU
005 20031021190100.0
008 020626s2003 nyua b 001 0 eng
010 |a  2002026546 
020 |a 0071370889 
035 |a 2002026546 
040 |a DLC  |c DLC  |d DLC  |d OCoLC  |d OrLoB-B 
042 |a pcc 
050 1 0 |a RC667  |b .H355 2003 
082 0 0 |a 616.1/2  |2 21 
245 0 0 |a Harrison's advances in cardiology /  |c [edited by] Eugene Braunwald. 
246 3 0 |a Advances in cardiology 
260 |a New York :  |b McGraw-Hill,  |c c2003. 
300 |a xxvii, 645 p. :  |b ill. (some col.) ;  |c 24 cm. 
336 |a text  |b txt  |2 rdacontent  |0 http://id.loc.gov/vocabulary/contentTypes/txt 
337 |a unmediated  |b n  |2 rdamedia  |0 http://id.loc.gov/vocabulary/mediaTypes/n 
338 |a volume  |b nc  |2 rdacarrier  |0 http://id.loc.gov/vocabulary/carriers/nc 
504 |a Includes bibliographical references and index. 
505 0 0 |g Ch. 1.  |t Chlamydia Pneumoniae and Coronary Artery Disease /  |r J. Ward Kennedy --  |g Ch. 2.  |t Angiotensin II, Oxidative Stress, and Atherosclerosis /  |r Bradford C. Berk --  |g Ch. 3.  |t Effect of Aldosterone on the Vascular Bed: Introducing the Aldosterone-Induced Vasculopathy /  |r Allan D. Struthers --  |g Ch. 4.  |t Homocysteine, Vitamins, and Coronary Artery Disease /  |r Peter W. F. Wilson --  |g Ch. 5.  |t The Link between Aortic Sclerosis and Atherosclerosis /  |r Catherine M. Otto --  |g Ch. 6.  |t Triglycerides and Low HDL in Coronary Risk Assessment /  |r Dennis L. Sprecher --  |g Ch. 7.  |t Gemfibrozil in the Secondary Prevention of Coronary Heart Disease: The VA-HIT Trial /  |r Hanna Bloomfield Rubins, Dorothea Collins and Sander J. Robins --  |g Ch. 8.  |t Intensive Life-Style Changes in Management of Coronary Heart Disease /  |r Dean Ornish --  |g Ch. 9.  |t The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study /  |r Andrew M. Tonkin --  |g Ch. 10.  |t Effects of Erythropoietin Therapy and Anemia Correction on Blood Pressure and Left Ventricular Function and Structure /  |r Nosratola D. Vaziri --  |g Ch. 11.  |t Hypertension and Sleep Apnea /  |r Patrick Hanly and Victor Hoffstein --  |g Ch. 12.  |t The Effect of Diet on Blood Pressure /  |r Lawrence J. Appel --  |g Ch. 13.  |t Angiotensin Receptor Blockers in the Treatment of Hypertension /  |r Irene Gavras and Haralambos Gavras --  |g Ch. 14.  |t Effect of Ramipril versus Amlodipine on Renal Outcomes in Hypertensive Nephrosclerosis: The African-American Study of Kidney Disease and Hypertension Trial /  |r Janice G. Douglas --  |g Ch. 15.  |t The Treatment of Systolic Hypertension in the Elderly - Results of the Systolic Hypertension in Europe Trial /  |r Jan A. Staessen --  |g Ch. 16.  |t The Intensity of Treatment of Hypertension: The Hypertension Optimal Treatment (HOT) Study /  |r Alberto Zanchetti --  |g Ch. 17.  |t Renal Artery Stenting: Indications and Results /  |r James J. Crowley and Richard S. Stack --  |g Ch. 18.  |t Polymorphisms in the Factor VII Gene and the Risk of Myocardial Infarction /  |r Domenico Girelli and Roberto Corrocher --  |g Ch. 19.  |t Troponins in Cardiovascular Diagnosis and Assessment of Prognosis /  |r Allan S. Jaffe --  |g Ch. 20.  |t Cardiovascular Risks of Sexual Activity /  |r James E. Muller --  |g Ch. 21.  |t Outcome of Myocardial Infarction in Patients with Renal Failure /  |r Peter A. McCullough --  |g Ch. 22.  |t Efforts to Shorten Delay in Treatment of Acute Myocardial Infarction /  |r Russell V. Luepker --  |g Ch. 23.  |t Emergency Department Imaging for Suspected Coronary Artery Disease /  |r James E. Udelson --  |g Ch. 24.  |t Clopidogrel /  |r James J. Ferguson --  |g Ch. 25.  |t Low-Molecular-Weight Heparin in Non-ST Elevation Acute Coronary Syndrome /  |r David A. Morrow and Elliott M. Antman --  |g Ch. 26.  |t Third-Generation Fibrinolytics /  |r Robert E. Fowles --  |g Ch. 27.  |t Thrombolytic Therapy in Elderly Patients with Acute Myocardial Infarction /  |r Alan K. Berger and Harlan M. Krumholz --  |g Ch. 28.  |t The PACT Trial: Implications for a Facilitated Approach to Primary PTCA in Acute Myocardial Infarction /  |r Allan M. Ross --  |g Ch. 29.  |t Emergency Revascularization in Acute Myocardial Infarction Complicated by Cardiogenic Shock - Results of the SHOCK Trial /  |r Harvey White and Judith S. Hochman --  |g Ch. 30.  |t When Should Statin Therapy Begin Following an Acute Coronary Syndrome? /  |r Scott Kinlay --  |g Ch. 31.  |t The Echocardiographic Technique of Choice in the Assessment of Coronary Artery Disease /  |r Theodore J. Kolias and William F. Armstrong --  |g Ch. 32.  |t Coronary Heart Disease and Diabetes Mellitus /  |r Steven P. Marso and Stephen G. Ellis --  |g Ch. 33.  |t Cardiovascular Disease and Erectile Dysfunction /  |r Robert A. Kloner --  |g Ch. 34.  |t SPECT Myocardial Imaging for the Detection of Hibernating Myocardium /  |r Vasken Dilsizian --  |g Ch. 35.  |t Detection of Vulnerable Coronary Artery Plaque Using Magnetic Resonance Imaging /  |r Valentin Fuster and Zahi A. Fayad --  |g Ch. 36.  |t Electron Beam Tomography for Early Detection of Coronary Artery Disease /  |r Tracy Q. Callister and Paolo Raggi --  |g Ch. 37.  |t The Heart Outcomes Prevention Evaluation (HOPE) Study Testing Ramipril and/or Vitamin E in Subjects at High Risk of Cardiovascular Events /  |r Peter Sleight --  |g Ch. 38.  |t Advances in Clinical Therapeutic Myocardial Angiogenesis /  |r Shmuel Fuchs, Eugenio Stabile, Richard Baffour and Stephen E. Epstein --  |g Ch. 39.  |t BFGF Trials for Patients with Advanced Coronary Disease /  |r Michael Simons, Mark J. Post, Roger J. Laham and Frank W. Sellke --  |g Ch. 40.  |t VEGF Gene Therapy in Patients with Severe Coronary Disease /  |r Douglas W. Losordo, Peter R. Vale, James F. Symes and Jeffrey M. Isner --  |g Ch. 41.  |t Catheter-Based Radiation Therapy to Prevent Restenosis Following Percutaneous Coronary Interventions /  |r Paul S. Teirstein --  |g Ch. 42.  |t Comparison of Angioplasty and Coronary Bypass Surgery in Diabetics: Seven-Year Outcome of the BARI Trial /  |r Katherine M. Detre, Robert C. Brooks and Maria Mori Brooks --  |g Ch. 43.  |t Coronary Angioplasty Volumes and Outcomes /  |r Charles Maynand, Nathan R. Every and James L. Ritchie --  |g Ch. 44.  |t Minimally Invasive Coronary Surgery /  |r Valavanur A. Subramanian and Nilesh U. Patel --  |g Ch. 45.  |t Intravascular Ultrasound Insights into Transplant Vasculopathy /  |r Samir R. Kapadia and E. Murat Tuzcu --  |g Ch. 46.  |t Prinzmetal's Variant Angina: A Contemporary Perspective /  |r John Beltrame --  |g Ch. 47.  |t Management of Atrial Septal Defect /  |r Abraham Rothman --  |g Ch. 48.  |t Coarctation of the Aorta in the Adult /  |r Gordon Mack, Grant H. Burch and David J. Sahn --  |g Ch. 49.  |t The Changing Spectrum of Valvular Heart Disease Pathology /  |r William D. Edwards --  |g Ch. 50.  |t Echocardiography and the Selection of Patients for Mitral Balloon Angioplasty /  |r Charles J. Bruce and Charanjit S. Rihal --  |g Ch. 51.  |t Percutaneous Mitral Commissurotomy /  |r Zoltan G. Turi --  |g Ch. 52.  |t Predictors of Outcome in Severe Asymptomatic Aortic Stenosis /  |r Raphael Rosenhek and Helmut Baumgartner --  |g Ch. 53.  |t The Stentless Aortic Prosthesis for Aortic Valve Replacement /  |r Donald B. Doty and John R. Doty --  |g Ch. 54.  |t Balloon Valvuloplasty for Aortic Stenosis /  |r Andrew D. Michaels and Thomas A. Ports --  |g Ch. 55.  |t Timing of Operation for Asymptomatic Severe Aortic Regurgitation /  |r Robert O. Bonow --  |g Ch. 56.  |t Surgery for Patients with Tricuspid Regurgitation /  |r Charles J. Mullany --  |g Ch. 57.  |t The Genetics of Atrial Fibrillation /  |r Robert Roberts and Ramon Brugada --  |g Ch. 58.  |t The Brugada Syndrome /  |r Ihor Gussak and Bernard R. Chaitman --  |g Ch. 59.  |t Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy /  |r Hugh Calkins and Frank I. Marcus --  |g Ch. 60.  |t Sudden Death in Hypertrophic Cardiomyopathy /  |r Barry J. Maron --  |g Ch. 61.  |t Newer Approaches to Management of the Long QT Syndrome /  |r Peter J. Schwartz and Silvia G. Priori --  |g Ch. 62.  |t Ibutilide: A New Antiarrhythmic Agent /  |r Hakan Oral and Fred Morady --  |g Ch. 63.  |t Nonpharmacologic Treatment of Atrial Fibrillation /  |r Mark E. Josephson --  |g Ch. 64.  |t Management of Postoperative Atrial Fibrillation /  |r David B. Bharucha and Peter R. Kowey --  |g Ch. 65.  |t Atrial Fibrillation Trials /  |r D. George Wyse --  |g Ch. 66.  |t Recent Clinical Trials with Amiodarone /  |r William G. Stevenson --  |g Ch. 67.  |t Transesophageal Echo-Guided Cardioversion of Atrial Fibrillation /  |r Warren J. Manning --  |g Ch. 68.  |t Cardiac Arrest: Newer Therapeutic Concepts /  |r Karl B. Kern --  |g Ch. 69.  |t Indications for the Implanted Cardioverter Defibrillator /  |r Alfred E. Buxton --  |g Ch. 70.  |t Myocyte Apoptosis in the Development of Heart Failure /  |r Piero Anversa --  |g Ch. 71.  |t Tumor Necrosis Factor in Heart Failure /  |r Douglas L. Mann --  |g Ch. 72.  |t Lamin A/C Mutations in Familial Dilated Cardiomyopathy /  |r Matthew R. G. Taylor and Luisa Mestroni --  |g Ch. 73.  |t Effect of Anemia in Severe Congestive Heart Failure /  |r Donald S. Silverberg, Dov Wexler and Adrian Iaina --  |g Ch. 74.  |t B-Type Natriuretic Peptide (BNP) Levels: A Potential Novel "White Count" for Congestive Heart Failure /  |r Alan Maisel --  |g Ch. 75.  |t Therapy of Diastolic Dysfunction in Hypertension and Hypertrophic Cardiomyopathy /  |r Gretchen Wells and William C. Little --  |g Ch. 76.  |t The Role of Aldosterone in Heart Failure - Results of the RALES Trial /  |r Peter Liu and Bertram Pitt -- 
505 8 0 |g Ch. 77.  |t Inotropic Infusions in Heart Failure /  |r Carl V. Leier --  |g Ch. 78.  |t Pacemaker Therapy for Refractory Heart Failure /  |r Vineet Kaushik, Teresa De Marco and Leslie A. Saxon --  |g Ch. 79.  |t When to Use Implantable Cardioverter Defibrillators in Heart Failure /  |r Bartolomeo Giannattasio and Mark D. Carlson --  |g Ch. 80.  |t Pacing in Hypertrophic Cardiomyopathy /  |r David A. Kass --  |g Ch. 81.  |t Echocardiography to Determine Viability in Heart Failure /  |r William A. Zoghbi --  |g Ch. 82.  |t Surgical Alternatives for the Failing Heart /  |r Patrick M. McCarthy and Katherine J. Hoercher --  |g Ch. 83.  |t Management of the Cardiac Transplant Patient /  |r Maria Rosa Costanzo --  |g Ch. 84.  |t Implantable Left Ventricular Assist Devices /  |r Nicholas G. Smedira --  |g Ch. 85.  |t Bridge to Transplantation with Mechanical Assist Devices /  |r Jack G. Copeland III --  |g Ch. 86.  |t Cardiac Replacement Therapy - Development of the AbioCor Implantable Replacement Heart /  |r Robert D. Dowling and Laman A. Gray, Jr. --  |g Ch. 87.  |t Stem Cell Therapy in Cardiac Injury /  |r Takayuki Saito, Jih Shiuan Wang and Ray C.-J. Chiu --  |g Ch. 88.  |t Venous Ultrasonography in the Diagnosis of Pulmonary Embolism /  |r Clive Kearon and Jeffrey S. Ginsberg --  |g Ch. 89.  |t Efficacy and Cost-effectiveness of Low Molecular Weight Heparins for Treatment of Acute Deep-Venous Thrombosis /  |r Michael K. Gould --  |g Ch. 90.  |t The Ankle Brachial Index in the Evaluation of Peripheral Arterial Disease /  |r Mary McGrae McDermott --  |g Ch. 91.  |t Cilostazol and Pentoxifylline in the Management of Intermittent Claudication /  |r David L. Dawson --  |g Ch. 92.  |t Urokinase or Vascular Surgery in the Treatment of Acute Arterial Occlusion: The TOPAS Trial /  |r Kenneth Ouriel --  |g Ch. 93.  |t Annuloaortic Ectasia and the Marfan Syndrome: From Genetics to Management /  |r Kenton J. Zehr --  |g Ch. 94.  |t Catheter-Based Treatment of Subacute Aortic Dissection /  |r Christoph A. Nienaber --  |g Ch. 95.  |t Endovascular Stent-Graft Placement in the Treatment of Aortic Dissection /  |r Gus J. Vlahakes --  |g Ch. 96.  |t Peripheral Vascular Therapy (Brachytherapy) for the Prevention of Restenosis Following Angioplasty /  |r Zvonimir Krajcer --  |g Ch. 97.  |t Management of Atheroembolic Disease /  |r John E. Scoble --  |g Ch. 98.  |t Practical Guidelines for Smoking Cessation /  |r Carolyn M. Dresler and Saul Shiffman --  |g Ch. 99.  |t Lung Transplantation for Pulmonary Hypertension /  |r Thomas L. Spray and Nancy D. Bridges --  |g Ch. 100.  |t Hereditary Hemochromatosis: A Risk Factor for Cardiovascular Disease /  |r Mark Roest, Yvonne T. Marx and J. J. M. Marx. 
583 1 |a committed to retain  |c 20170930  |d 20421213  |f HathiTrust  |5 ICU 
650 0 |a Cardiology.  |0 http://id.loc.gov/authorities/subjects/sh85020214 
650 0 |a Cardiovascular system  |x Diseases  |x Treatment.  |0 http://id.loc.gov/authorities/subjects/sh92001811 
650 7 |a Cardiology.  |2 fast  |0 http://id.worldcat.org/fast/fst00847121 
650 7 |a Cardiovascular system  |x Diseases  |x Treatment.  |2 fast  |0 http://id.worldcat.org/fast/fst00847218 
700 1 |a Braunwald, Eugene,  |d 1929-  |0 http://id.loc.gov/authorities/names/n79027082  |1 http://viaf.org/viaf/84827943 
901 |a ToCBNA 
903 |a HeVa 
903 |a Hathi 
035 |a (OCoLC)50090131 
929 |a cat 
999 f f |i 466e82af-903b-549c-b547-b47118ccced5  |s 3caa2e59-881e-512b-bf86-a9d6cc3f5590 
928 |t Library of Congress classification  |a RC667 .H355 2003  |l JCL  |c JCL-Sci  |i 4610665 
927 |t Library of Congress classification  |a RC667 .H355 2003  |l JCL  |c JCL-Sci  |e BILL  |e CRERAR  |b 63151764  |i 7358065 
Billings Collection Presented by Dr. Frank Billings bookplate
The John Crerar Library bookplate

Similar Items